Angiographic imaging system vendors have developed new technologies to address emerging cath lab trends, including the need to reduce radiation dose, improve image quality and enable advanced procedural image guidance. All three of these points have become increasingly important as more complex procedures are attempted in interventional cath labs and hybrid ORs.


July 12, 2016 — Following a collaborative process with the U.S. Food and Drug Administration (FDA), Alere Inc. will be initiating a voluntary withdrawal of the Alere INRatio and INRatio 2 PT/INR Monitoring System.

The updated American College of Radiology (ACR) Manual on Contrast Media contains a statement addressing the U.S. Food and Drug Administration (FDA) safety communication on use of gadolinium-based contrast agents for magnetic resonance imaging (MRI).


With the recent introduction of several novel oral anticoagulants (NOACs) on the U.S. market that have been billed by the drug makers as possible replacements for warfarin (Coumadin), there are several clinical considerations when comparing these agents.


University Hospitals Case Medical Center, Cleveland, is among the first in the country – and the first in Ohio — to offer and deploy the Abbott Absorb stent, a completely bioresorbable stent.

ContextVision has signed a contract to bring its US PLUSView ultrasound image enhancement software to hand-held iOS-based mobile devices.


There were several overall key trends evident at the 2016 meeting of the American Society of Echocardiography in June. These included echo playing a key role in structural heart evaluation and for procedural guidance, ways to reduce operator variability and increase reproducibility of cardiac exams, new emphasis on use of contrast echo and strain imaging, and a proliferation of hand-held ultrasound systems for point-of-care cardiovascular assessments.

 


Kirk Schoenherr, 56, of Clinton Township, Mich., recently became just the second patient at Beaumont Hospital, Royal Oak, to receive conscious sedation for thoracic aortic aneurism repair.

University of Guelph researchers have uncovered a possible clue as to why women have lower rates of heart failure than men for most of their lives. The key seems to be an actin binding protein called “CapZ” that also protects against heart attacks.

Subscribe Now